Product Images Twirla

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 23 images provide visual information about the product associated with Twirla NDC 71671-100 by Agile Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

fig2a

fig2a

This is a list of studies that compare the use of combined oral contraceptive (COC) and the risk of certain outcomes. The studies examine different populations and use different measures of effect, such as odds ratios (OR), relative risks (RR), and hazard ratios (HR). The outcomes studied are not specified in the given text.*

figure-1 - figure 1

figure-1 - figure 1

This appears to be a medical chart that displays information about a certain group of non-pregnant women who are CHC Users. It also provides information about pregnancy and postpartum. The chart includes ranges for several different variables such as 1105 and 3012. There is also a graph that shows the number of women with a blood clot out of 10,000 Woman-Years (W).*

figure-2 - figure 2

figure-2 - figure 2

Lovonorgestrel is a chemical compound with molecular formula CaiH2:02 and molecular weight 312.45. Pyl Estradial is another chemical compound with molecular formula CaoHzO2 and molecular weight 296.41. These compounds may be used in medical and pharmaceutical applications, but further context is needed to determine their specific uses.*

figure-3 - figure 3

figure-3 - figure 3

This is a description of a woven peripheral backing layer for use in medical applications. The layer has an inactive peripheral acrylic adhesive layer and an inactive peripheral polyisobutylene adhesive layer. The layer also features an internal membrane and an active adhesive matrix. To prevent sticking, a polyester release liner is included.*

figure-4 - figure 4

figure-4 - figure 4

figure-5 - figure 5

figure-5 - figure 5

figure-6 - figure 6

figure-6 - figure 6

no-placement - no placement

no-placement - no placement

placement - placement

placement - placement

image description - twirla application 0

image description - twirla application 0

image description - twirla application 1

image description - twirla application 1

image description - twirla application 10

image description - twirla application 10

image description - twirla application 2

image description - twirla application 2

image description - twirla application 4

image description - twirla application 4

image description - twirla application 5

image description - twirla application 5

image description - twirla application 6

image description - twirla application 6

image description - twirla application 6a

image description - twirla application 6a

image description - twirla application 7

image description - twirla application 7

image description - twirla application 8

image description - twirla application 8

image description - twirla application 9

image description - twirla application 9

twirla-carton-1-replacement - twirla carton 1 replacement

twirla-carton-1-replacement - twirla carton 1 replacement

Twirla is a contraceptive patch containing norgestrel and ethinyl estradiol. It is designed to prevent pregnancy but does not protect against sexually transmitted diseases or HIV/AIDS. The package contains one replacement transdermal system intended for transdermal use only. The instructions on how to use the patch can be found on the prescribing information included inside the package.*

image description - twirla carton 3 trade

image description - twirla carton 3 trade

Description: This is a package of medication containing a contraceptive patch containing a combination of levonorgestrel and ethinyl estradiol. It is recommended for transdermal use only to prevent pregnancy and protect against sexually transmitted infections. The package contains 2 patches and its contents include a transdermal system. Recommended dosages are provided along with the components of the medication. The text includes details such as temperature and storage guidelines.*

image description - twirla pouch

image description - twirla pouch

This is a description of a contraceptive transdermal patch that contains levonorgestel and efiny esiraiol. The patch is intended to prevent pregnancy but does not protect against sexually transmitted diseases. The recommended dosage is to apply the patch immediately upon its removal from the pouch and wear it for seven days before discarding it. The product should be stored at room temperature. It is not recommended to flush used transdermal systems down the toilet.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.